291. ヒルシュスプルング病(全結腸型又は小腸型) Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 12 / 薬物数 : 24 - (DrugBank : 15) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
Bifico
Tongji Hospital
2008 Phase 0 NCT01934959 -
Butyrate enemas + routine management
Assistance Publique Hopitaux De Marseille
2019 Phase 3 NCT03660176 France;
Cefazolin
McMaster University
2018 - NCT03593252 -
Erythromycin
McMaster University
2018 - NCT03593252 -
Gold
Radboud University
2021 - NCT04624334 Netherlands;
Xinhua Hospital, Shanghai Jiaotong University School of Medicine
2020 Phase 0 ChiCTR2000035860 China;
High dose lactulose
Tongji Hospital
2013 - NCT02216994 China;
Indocyanine green
Lawson Health Research Institute
2021 Phase 3 NCT04904081 Canada;
Kanamycin
McMaster University
2018 - NCT03593252 -
Metronidazole
McMaster University
2018 - NCT03593252 -
Oral probiotic
Tongji Hospital
2009 Phase 0 NCT01985646 -
Probiotics
Cairo University
2014 Phase 4 NCT02343562 Egypt;
Tongji Hospital
2014 - NCT02350088 China;
Racol
University of Tsukuba Hospital
2016 - JPRN-UMIN000024993 Japan;
SPY imaging
St. Justine's Hospital
2020 - NCT04020939 Canada;
Senna
McMaster University
2018 - NCT03593252 -
Sodium Picosulfate, Magnesium Oxide and Citric Acid
McMaster University
2018 - NCT03593252 -
Supplement nutritional supporting
Tongji Hospital
2021 - NCT04598841 China;
Surgery treatment
Tongji Hospital
2009 Phase 0 NCT01985646 -
VSL#3
University of Michigan
2006 Phase 2 NCT00630838 United States;
Tongji Hospital
2008 Phase 0 NCT01934959 -
Butyrate enemas + routine management
Assistance Publique Hopitaux De Marseille
2019 Phase 3 NCT03660176 France;
Cefazolin
McMaster University
2018 - NCT03593252 -
Erythromycin
McMaster University
2018 - NCT03593252 -
Gold
Radboud University
2021 - NCT04624334 Netherlands;
Xinhua Hospital, Shanghai Jiaotong University School of Medicine
2020 Phase 0 ChiCTR2000035860 China;
High dose lactulose
Tongji Hospital
2013 - NCT02216994 China;
Indocyanine green
Lawson Health Research Institute
2021 Phase 3 NCT04904081 Canada;
Kanamycin
McMaster University
2018 - NCT03593252 -
Metronidazole
McMaster University
2018 - NCT03593252 -
Oral probiotic
Tongji Hospital
2009 Phase 0 NCT01985646 -
Probiotics
Cairo University
2014 Phase 4 NCT02343562 Egypt;
Tongji Hospital
2014 - NCT02350088 China;
Racol
University of Tsukuba Hospital
2016 - JPRN-UMIN000024993 Japan;
SPY imaging
St. Justine's Hospital
2020 - NCT04020939 Canada;
Senna
McMaster University
2018 - NCT03593252 -
Sodium Picosulfate, Magnesium Oxide and Citric Acid
McMaster University
2018 - NCT03593252 -
Supplement nutritional supporting
Tongji Hospital
2021 - NCT04598841 China;
Surgery treatment
Tongji Hospital
2009 Phase 0 NCT01985646 -
VSL#3
University of Michigan
2006 Phase 2 NCT00630838 United States;